All In Biotech

Drug Trial Radar · NCT02348203

Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers

Clinical Study of the Effect of Combined Treatment of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers

Last checked: Nov 20, 2026Latest source record: Jun 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

63

Actual

Start

Jan 13, 2016

Primary completion

Feb 22, 2019

Study completion Mar 9, 2021

Sponsor

Sponsor type
NIH
First posted
Jan 28, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This randomized phase II trial studies the effects of aspirin and zileuton on genes related to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to tobacco use and may be useful in preventing lung cancer in current smokers.

Conditions

  • Tobacco Use Disorder

Interventions

  • AspirinDrug

    Given PO

  • Laboratory Biomarker AnalysisOther

    Correlative studies

  • Placebo AdministrationOther

    Given aspirin placebo PO

  • Placebo AdministrationOther

    Given zileuton placebo PO

  • ZileutonDrug

    Given PO

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in a Smoking-related Gene Expression Signature Score in the Nasal Epithelium of Current SmokersTime frame: Baseline to 12 weeks (End-of-intervention)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Banner University Medical Center - Tucson

    Tucson, Arizona

  • Boston University School of Medicine

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.